SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    S.R. Jahromi, M. Haddadi, T. Shivanandappa, S.R. Ramesh, Attenuation of neuromotor deficits by natural antioxidants of Decalepis hamiltonii in transgenic Drosophila model of Parkinson’s disease, Neuroscience, 2015, 293, 136

    CrossRef

  2. 2
    Yoon-Sang Oh, Joong-Seok Kim, Yeong-In Kim, Dong-Won Yang, Ja-Seong Koo, Hae Ok Jung, Kwang-Soo Lee, Circadian blood pressure and heart rate variations inde novoParkinson’s disease, Biological Rhythm Research, 2014, 45, 3, 335

    CrossRef

  3. 3
    Michele A Faulkner, Safety overview of FDA-approved medications for the treatment of the motor symptoms of Parkinson’s disease, Expert Opinion on Drug Safety, 2014, 13, 8, 1055

    CrossRef

  4. 4
    Scott J. Kutscher, Siavash Farshidpanah, Daniel O. Claassen, Sleep Dysfunction and its Management in Parkinson’s Disease, Current Treatment Options in Neurology, 2014, 16, 8

    CrossRef

  5. 5
    William G. Ondo, Sleep/wake problems in Parkinson’s disease: pathophysiology and clinicopathologic correlations, Journal of Neural Transmission, 2014, 121, S1, 3

    CrossRef

  6. 6
    L. David Willison, Takashi Kudo, Dawn H. Loh, Dika Kuljis, Christopher S. Colwell, Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson's disease: Insights from a transgenic mouse model, Experimental Neurology, 2013, 243, 57

    CrossRef

  7. 7
    Fiona Hawke, Vivienne Chuter, Joshua Burns, Impact of nocturnal calf cramping on quality of sleep and health-related quality of life, Quality of Life Research, 2013, 22, 6, 1281

    CrossRef

  8. 8
    Sun Young Rosalia Yoon, Umesh Ravi Jain, Colin Michael Shapiro, Sleep and daytime function in adults with attention-deficit/hyperactivity disorder: subtype differences, Sleep Medicine, 2013, 14, 7, 648

    CrossRef

  9. 9
    M. Zibetti, M. Rizzone, A. Merola, S. Angrisano, L. Rizzi, E. Montanaro, A. Cicolin, L. Lopiano, Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson disease, Acta Neurologica Scandinavica, 2013, 127, 5
  10. You have free access to this content10
    J. J. Ferreira, R. Katzenschlager, B. R. Bloem, U. Bonuccelli, D. Burn, G. Deuschl, E. Dietrichs, G. Fabbrini, A. Friedman, P. Kanovsky, V. Kostic, A. Nieuwboer, P. Odin, W. Poewe, O. Rascol, C. Sampaio, M. Schüpbach, E. Tolosa, C. Trenkwalder, A. Schapira, A. Berardelli, W. H. Oertel, Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease, European Journal of Neurology, 2013, 20, 1
  11. 11
    Pedro Lax, Gema Esquiva, Julian Esteve-Rudd, Beatriz Baño Otalora, Juan Antonio Madrid, Nicolás Cuenca, Circadian Dysfunction in a Rotenone-Induced Parkinsonian Rodent Model, Chronobiology International, 2012, 29, 2, 147

    CrossRef

  12. 12
    Santiago Perez-Lloret, María Verónica Rey, Nelly Fabre, Fabienne Ory, Umberto Spampinato, Jean-Louis Montastruc, Olivier Rascol, Do Parkinson’s disease patients disclose their adverse events spontaneously?, European Journal of Clinical Pharmacology, 2012, 68, 5, 857

    CrossRef

  13. 13
    Maartje Louter, Marten Munneke, Bastiaan R. Bloem, Sebastiaan Overeem, Nocturnal Hypokinesia and Sleep Quality in Parkinson's Disease, Journal of the American Geriatrics Society, 2012, 60, 6
  14. 14
    Paul S. Foster, Valeria Drago, Gregory P. Crucian, William K. Sullivan, Robert D. Rhodes, Brian V. Shenal, Barry Skoblar, Frank M. Skidmore, Kenneth M. Heilman, Anxiety and depression severity are related to right but not left onset Parkinson's disease duration, Journal of the Neurological Sciences, 2011, 305, 1-2, 131

    CrossRef

  15. 15
    Takashi Kudo, Dawn H. Loh, Danny Truong, Yingfei Wu, Christopher S. Colwell, Circadian dysfunction in a mouse model of Parkinson's disease, Experimental Neurology, 2011, 232, 1, 66

    CrossRef

  16. 16
    Olivier Rascol, Andres Lozano, Matthew Stern, Werner Poewe, Milestones in Parkinson's disease therapeutics, Movement Disorders, 2011, 26, 6
  17. 17
    Raja Mehanna, William G Ondo, Sleep problems in Parkinson’s disease patients, Neurodegenerative Disease Management, 2011, 1, 4, 307

    CrossRef

  18. 18
    Santiago Perez-Lloret, Olivier Rascol, Dopamine Receptor Agonists for the Treatment of Early or Advanced Parkinsonʼs Disease, CNS Drugs, 2010, 24, 11, 941

    CrossRef

  19. 19
    Roberto Ceravolo, Carlo Rossi, Lorenzo Kiferle, Ubaldo Bonuccelli, Nonmotor symptoms in Parkinson’s disease: the dark side of the moon, Future Neurology, 2010, 5, 6, 851

    CrossRef

  20. 20
    Birgit Högl, Isabelle Arnulf, Cynthia Comella, Joaquim Ferreira, Alex Iranzo, Barbara Tilley, Claudia Trenkwalder, Werner Poewe, Olivier Rascol, Cristina Sampaio, Glenn T. Stebbins, Anette Schrag, Christopher G. Goetz, Scales to assess sleep impairment in Parkinson's disease: Critique and recommendations, Movement Disorders, 2010, 25, 16
  21. 21
    Angelo Antonini, Eduardo Tolosa, Yoshikuni Mizuno, Mitsutoshi Yamamoto, Werner H Poewe, A reassessment of risks and benefits of dopamine agonists in Parkinson's disease, The Lancet Neurology, 2009, 8, 10, 929

    CrossRef

  22. 22
    K. Ray Chaudhuri, Kartik Logishetty, Dopamine receptor agonists and sleep disturbances in Parkinson's disease, Parkinsonism & Related Disorders, 2009, 15, S101

    CrossRef

  23. 23
    Eva Havlikova, Jitse P. van Dijk, Jaroslav Rosenberger, Iveta Nagyova, Berrie Middel, Tatiana Dubayova, Zuzana Gdovinova, Johan W. Groothoff, Fatigue in Parkinson's disease is not related to excessive sleepiness or quality of sleep, Journal of the Neurological Sciences, 2008, 270, 1-2, 107

    CrossRef

  24. 24
    Ubaldo Bonuccelli, Roberto Ceravolo, The safety of dopamine agonists in the treatment of Parkinson's disease, Expert Opinion on Drug Safety, 2008, 7, 2, 111

    CrossRef

  25. 25
    Birgit Högl, Handbook of Sleep Disorders, Second Edition, 2008,

    CrossRef

  26. 26
    Imad Ghorayeb, Anderson Loundou, Pascal Auquier, Yves Dauvilliers, Bernard Bioulac, François Tison, A nationwide survey of excessive daytime sleepiness in Parkinson's disease in France, Movement Disorders, 2007, 22, 11
  27. 27
    Aleksandar Videnovic, Tanya Simuni, Managing sleep disorders in Parkinson’s disease, Aging Health, 2007, 3, 1, 49

    CrossRef

  28. 28
    Cynthia L. Comella, Sleep disorders in Parkinson's disease: An overview, Movement Disorders, 2007, 22, S17
  29. 29
    Theresa A Zesiewicz, Kelly L Sullivan, Robert A Hauser, Nonmotor symptoms of Parkinson’s disease, Expert Review of Neurotherapeutics, 2006, 6, 12, 1811

    CrossRef

  30. 30
    W. H. Oertel, A. Berardelli, B. R. Bloem, U. Bonuccelli, D. Burn, G. Deuschl, E. Dietrichs, G. Fabbrini, J. J. Ferreira, A. Friedman, P. Kanovsky, V. Kostic, A. Nieuwboer, P. Odin, W. Poewe, O. Rascol, C. Sampaio, M. Schüpbach, E. Tolosa, C. Trenkwalder, Late (Complicated) Parkinson's Disease,
  31. 31
    Joaquim Ferreira, Tiago Mestre, Russell M Hewett, Miguel M Coelho, Mário Rosa, Olivier Rascol, Cristina Sampaio, Therapeutic interventions for daytime somnolence in Parkinson's disease, The Cochrane Library,
  32. 32
    Joaquim Ferreira, Tiago Mestre, Russell M Hewett, Miguel M Coelho, Mário Rosa, Olivier Rascol, Cristina Sampaio, Therapeutic interventions for sleep disorders in Parkinson's disease, The Cochrane Library,